There are a lot of misconceptions around DKA, or diabetic ketoacidosis. It’s a common but very serious acute complication that develops when someone who is insulin dependent loses access to insulin (your pump line falls out, etc). Drs. Edelman and Pettus explain the causes, symptoms, and treatment.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
